Sachpekidis, Christos; Exadaktylou, Paraskevi; Katsampoukas, Dimitrios; Moralidis, Efstratios; Arsos, Georgios (2020). 18F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan. Hellenic journal of nuclear medicine, 23(1), pp. 76-78. 10.1967/s002449912006
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
HJNM_Burkitt.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy |
Peritoneal lymphomatosis, defined as the disseminated intraperitoneal lymphomatous infiltration, is a rare presentation usually of non-Hodgkin lymphoma and is associated with aggressive histological subtypes of the malignancy. Recently, the term "peritoneal super scan" has been introduced in positron emission tomography/computed tomography (PET/CT) in a patient with Burkitt lymphoma to describe hypermetabolic lymphomatous involvement of the entire peritoneum, leading to suppression of tracer uptake in organs with otherwise normally increased fluorine-18-fluorodeoxyglucose (18F-FDG) uptake. Herein, we report on a patient with Burkitt lymphoma, initially presenting with a peritoneal super scan in PET/CT demonstrating complete metabolic response to R-CHOP (rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone) therapy.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine |
UniBE Contributor: |
Sachpekidis, Christos |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1790-5427 |
Language: |
English |
Submitter: |
Sabine Lanz |
Date Deposited: |
29 Dec 2020 12:55 |
Last Modified: |
05 Dec 2022 15:42 |
Publisher DOI: |
10.1967/s002449912006 |
PubMed ID: |
32222732 |
BORIS DOI: |
10.48350/149126 |
URI: |
https://boris.unibe.ch/id/eprint/149126 |
Actions (login required)
 |
Edit item |